Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT
Year: 2023
Type: article
Source: Biochemical Pharmacology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4367837738
